Non-profit diseases

There is a logic to the idea of neglected diseases. Historically the diseases poor people get--largely in the poorer parts of the world--haven't …

For government's eyes only...

The Indian official machinery has excelled for 50 years in keeping secrets. But with the right to information campaign gaining momentum, people …

Swarm warning

Officials claim the locust problem is under control, but unless millions of hoppers -- young locusts -- stalking the deserts are exterminated …

Hypothetical cure

Unlike allopathic medicines, Ayurvedic products are not clinically tested before they are introduced in the market. This raises doubts about …

Hell in Europe's back yard

Cancer and air pollution go hand in hand in eastern Europe, where an ecological nightmare is still unfolding

Public vs profit

The public sector giant did the right thing for the wrong reason

Deluge of foreign patent applications in India

White gold rush

Despite several government programmes, cotton cultivation is riddled with problems

Deadly concoctions

Farmers are not fully aware of the consequences of using chemical pesticides

China remains heavily polluted, despite regulations

Yet another white paper but little work on the ground

Panchayats to get poverty alleviation funds

India's fertiliser subsidy policy favours the industry

Government's subsidy policy remains pro-industry

Food and malnutrition

Maharashtra set to notify standards for private healthcare units

Politics behind Maharashtra's milk strike

Indian Forest Service officials complain of anomalies in revised pay scales

Will Indian generosity help Africa?

Chirala saree weavers losing out to computer-aided designs

Oil companies imperil polar bear habitat

Managing freshwater resources

Industrial vibes

Will solutions of the North work in the South?

Water in foreign policy

The global community is slowly waking up to the growing paucity of water

A parched waterworld

Not just humans, nature also needs water

Australia grows more sandalwood than India

Ranbaxy fights Pfizer on generic drugs but wants strong home law on patents